Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1449, 2004-01, pp. : 5-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is early intervention with biological agents worthwhile in RA?
Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. :
Access to resources
Recommend
Folate supplementation + methotrexate worthwhile in RA?
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :
Etanercept in RA: will it crack the early disease market?
Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. :
Infliximab, etanercept in RA discussed
Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. :
Etanercept/infliximab: Colitis and Crohn's disease?: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1348-1349, 2011-01 ,pp. :